This minimally invasive and cost-effective alternative to tissue biopsy offers “an accessible tool for tailoring treatment strategies in breast cancer,” researchers reported April 22 in the journal Science Translational Medicine.

These findings highlight the critical need for tumor genomic testing for all patients to identify those with high-risk tumors, which occur more frequently in Black women, and which require more aggressive treatment to prevent recurrence.

Lung cancer is the leading cause of cancer death in the United States, with incidence higher in veterans compared to the civilian population.

The grant extension will expand applications in research, clinical trials, registries and national collaborations.

Scientists from Vanderbilt University Medical Center and Vanderbilt University joined other advocates from Tennessee to share why continued bipartisan support for NIH is important to them.

Beginning in July 2026, Dupuis will coordinate all aspects of the internal medicine residency, including the interview and selection process, mentoring the residents going through the program.

The drug combo pembrolizumab plus axitinib had sustained and durable clinical benefit in more than five years of follow-up. It is a standard-of-care first-line treatment for advanced kidney cancer.